-
1.Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives 有权
标题翻译: Zusammensetzung und antivirale Wirkung von substitutionierten Azaindoloxoessigpiperazinderivaten公开(公告)号:EP2801576B1
公开(公告)日:2015-12-09
申请号:EP14164659.6
申请日:2003-08-05
发明人: Wang, Tao , Zhang, Zhongxing , Meanwell, Nicholas, A. , Kadow, John, F. , Yin, Zhiwei , Xue, Qiufen, May , Regueiro-Ren, Alicia , Matiskella, John, D. , Ueda, Yasutsugu
IPC分类号: C07D471/04 , C07D487/04 , A61K31/496 , A61K31/506 , A61K31/472 , A61K31/4725 , A61K31/427 , A61K31/4402 , A61P31/18 , A61K45/06
CPC分类号: A61K31/496 , A61K31/427 , A61K31/4402 , A61K31/472 , A61K31/4725 , A61K31/513 , A61K31/52 , A61K31/536 , A61K31/635 , A61K31/7068 , A61K31/7072 , A61K31/708 , C07D471/04 , A61K2300/00
-
2.Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives 有权
标题翻译: Zusammensetzung und antivirale Wirkung von substitutionierten Azaindoloxoessigpiperazinderivaten公开(公告)号:EP2801576A1
公开(公告)日:2014-11-12
申请号:EP14164659.6
申请日:2003-08-05
发明人: Wang, Tao , Zhang, Zhongxing , Meanwell, Nicholas, A. , Kadow, John, F. , Yin, Zhiwei , Xue, Qiufen, May , Regueiro-Ren, Alicia , Matiskella, John, D. , Ueda, Yasutsugu
IPC分类号: C07D471/04 , C07D487/04 , A61K31/496 , A61K31/506 , A61K31/427 , A61K31/4402 , A61K31/472 , A61K31/4725 , A61P31/18
CPC分类号: A61K31/496 , A61K31/427 , A61K31/4402 , A61K31/472 , A61K31/4725 , A61K31/513 , A61K31/52 , A61K31/536 , A61K31/635 , A61K31/7068 , A61K31/7072 , A61K31/708 , C07D471/04 , A61K2300/00
摘要: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and their use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives of the present claim 1. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, such as HIV protease inhibitors. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS.
摘要翻译: 本发明提供具有药物和生物影响性质的化合物,其药物组合物及其用途。 特别地,本发明涉及权利要求1的氮杂吲哚氧乙酰哌嗪衍生物。这些化合物具有独特的抗病毒活性,无论是单独使用还是与其它抗病毒剂如HIV蛋白酶抑制剂组合使用。 更具体地说,本发明涉及可用于治疗HIV和AIDS的化合物。
-
3.Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives 有权
标题翻译: 组合物和取代的衍生物Azaindoloxoessigpiperazin的抗病毒活性公开(公告)号:EP2497770B1
公开(公告)日:2014-05-14
申请号:EP12170639.4
申请日:2003-08-05
发明人: Wang, Tao , Zhang, Zhongxing , Meanwell, Nicholas, A. , Kadow, John, F. , Yin, Zhiwei , Xue, Qiufen, May , Regueiro-Ren, Alicia , Matiskella, John, D. , Ueda, Yasutsugu
IPC分类号: C07D471/04 , A61K31/496 , A61P31/12 , A61P31/18
CPC分类号: A61K31/496 , A61K31/427 , A61K31/4402 , A61K31/472 , A61K31/4725 , A61K31/513 , A61K31/52 , A61K31/536 , A61K31/635 , A61K31/7068 , A61K31/7072 , A61K31/708 , C07D471/04 , A61K2300/00
-
4.Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives 有权
标题翻译: Zusammensetzung und antivirale Wirkung von substitutionierten Azaindoloxoessigpiperazin Derivaten公开(公告)号:EP2497770A1
公开(公告)日:2012-09-12
申请号:EP12170639.4
申请日:2003-08-05
发明人: Wang, Tao , Zhang, Zhongxing , Meanwell, Nicholas, A. , Kadow, John, F. , Yin, Zhiwei , Xue, Qiufen, May , Regueiro-Ren, Alicia , Matiskella, John, D. , Ueda, Yasutsugu
IPC分类号: C07D471/04 , A61K31/496 , A61P31/12 , A61P31/18
CPC分类号: A61K31/496 , A61K31/427 , A61K31/4402 , A61K31/472 , A61K31/4725 , A61K31/513 , A61K31/52 , A61K31/536 , A61K31/635 , A61K31/7068 , A61K31/7072 , A61K31/708 , C07D471/04 , A61K2300/00
摘要: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and their use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS.
摘要翻译: 本发明提供具有药物和生物影响性质的化合物,其药物组合物及其用途。 特别地,本发明涉及氮杂吲哚乙酰基哌嗪衍生物。 这些化合物具有独特的抗病毒活性,无论是单独使用还是与其他抗病毒剂,抗感染剂,免疫调节剂或HIV进入抑制剂组合使用。 更具体地说,本发明涉及可用于治疗HIV和AIDS的化合物。
-
-
-